MedPage Today) -- SAN FRANCISCO -- A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of plasma concentrations compared with twice-yearly subcutaneous lenacapavir for HIV pre...
Copyright © 2024omega1medianewsglobalnetwork. All Rights Reserved http://www.endless5dollarpayments.com